Description

The Infant Bilirubin Phototherapy Unit YG0239 is an advanced and mobile medical device engineered specifically for the effective treatment of neonatal jaundice through phototherapy. This sophisticated unit utilizes five blue fluorescent tubes, emitting light within an optimal wavelength range of 400-550nm, crucial for breaking down bilirubin deposits in the skin. With a built-in LED digital timer, healthcare professionals can easily monitor both therapy and total operational times, ensuring a controlled and efficient treatment process. Its compact and mobile design facilitates easy relocation within neonatal care units, optimizing workflow and patient care.

Market Price

The Infant Bilirubin Phototherapy Unit YG0239 presents a competitively priced option within the market, typically ranging between $500 and $800, depending on the supplier and additional features within the package. As a highly efficient, durable, and mobile solution, it delivers excellent value for healthcare establishments seeking a dependable and economical method for neonatal jaundice treatment.

Frequently Asked Questions

• What is the ideal treatment distance? The YG0239 unit allows for an adjustable treatment range of 10px to 500px, ensuring optimal exposure by customizing its height according to the infant’s needs.
• How long before the light source needs replacement? The light source offers up to 1000 hours of effective use, ensuring long-lasting performance with minimal maintenance requirements.
• Is this device noisy during operation? Operating at a noise level of ≤55dB(A), the YG0239 remains quiet, ideal for sensitive environments like neonatal intensive care units (NICUs).

Advantages and Disadvantages

Advantages:

• Provides effective phototherapy with a broad treatment area (1125px x 600px).
• Energy-efficient consumption, requiring <150VA.
• Versatile adjustability in height and angles for personalized treatment options.
• Low operational noise makes it ideal for quiet environments.
• Long-lasting light source, offering reduced maintenance needs.

Disadvantages:

• Requires close monitoring of the treatment distance for optimal efficacy.
• Light source durability necessitates replacement approximately after 1000 hours of use.

Field Use

In clinical settings, the Infant Bilirubin Phototherapy Unit YG0239 is prominently used for treating neonatal jaundice. Its customizable features enable healthcare providers to adapt the treatment process to individual infants’ needs, ensuring thorough care while minimizing discomfort. The blue light effectively breaks down excess bilirubin in newborns’ bloodstreams, reducing jaundice symptoms and preventing potential complications.

Recommendations

To maximize the effectiveness and longevity of the YG0239, regular maintenance of its light source and digital timer is essential. Ensuring accurate placement at the optimal treatment distance enhances therapeutic outcomes and minimizes the risk of adverse effects.

Technical Specifications